001 VN Nov 2020

ESMO 2020: Oncology electronic prescribing record study of UK first-line (1L) NSCLC patients

Retrospective Analysis of Real-World Treatment Patterns and Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Starting First-Line Systemic Therapy in the United Kingdom Over 1,000 electronic prescribing records evaluated Rapid uptake of new treatment options in first-line Click here to read more About SVMPharma SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for […]

Read More
001 HM Oct 2020

COVID-19 clinical study of baricitinib and remdesivir set-up with the help of AI

The randomised control trial, which included more than 1,000 patients, began on May 8 to assess the efficacy and safety of baricitinib plus remdesivir versus remdesivir in hospitalised patients with COVID-19 The results of randomised trials, including the recently initiated global placebo-controlled study, are expected in the next few months “This data will allow us […]

Read More